Trials to overcome Ponaresistance by a modified molecular structure. May be the structure found is covered by the existing Ponatinib patent, if it is only a small modification?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.